Genetron Holdings Announces Its AYVAKIT Has Entered Priority Review And Approval Process In China
Genetron Holdings Limited (("Genetron Health" or the "Company", NASDAQ:GTH), today announced that its AYVAKIT® (avapritinib) companion diagnostic (CDx) kit, developed in partnership